| Estrogen is said to stimulate cellular tissue growth | | | | and as a substrate for the formation of adrenal |
| especially in the estrogen sensitive female | | | | cortical hormones. |
| reproductive organs. The hormone progesterone | | | | Like most endocrinology this concept is difficult |
| makes tissue more fertile and helps to control | | | | for the average person as well as many |
| duration and intensity of estrogenic effect. When | | | | physicians to fully comprehend.This concept is |
| a woman's estrogen or progesterone production | | | | important because, it demonstrates that the best |
| and tissue effects are balanced, normal menstrual | | | | way to address conditions such as abnormal |
| cycling continues until menopause. | | | | tissue growth and inflammation, is by providing |
| An imbalance in natural hormone levels, as well as | | | | the body with natural compounds that it can use |
| exposure to hormone-like substances | | | | to enhance processes that it already has in place |
| (xenosteroids) from pharmaceutical drugs and | | | | to decrease symptoms and potentially undo tissue |
| environmental factors, can evoke many | | | | changes. |
| disturbances in the female reproductive tissues. | | | | The inclusion of a DHEA supplement may |
| Such imbalances may trigger abnormal tissue | | | | indirectly increase progesterone synthesis and act |
| growth within the breast and other female | | | | to alleviate the need for available progesterone |
| reproductive areas. This activity within the uterus | | | | scavenged to promote a significant source for the |
| can lead to the development of fibrin nests and | | | | synthesis of estrogen; relying less on |
| eventually the growth of fibroids. | | | | progesterone as source for estrogen conversion |
| This is why Fibroid growth is thought by experts | | | | allowing progesterone to act freely opposing |
| to be closely related with estrogen dominance and | | | | estrogen. |
| is said to be a prime contributor to the | | | | FibroVera is a proprietary blend of microbial and |
| deregulation of normal function experienced by | | | | botanical components selected to address these |
| not only women approaching, transitioning, and | | | | hormonal imbalances. As mentioned earlier these |
| resolving the challenge of menopause, but also | | | | imbalances such as estrogen dominance activate |
| young women experiencing difficulty when fertility | | | | the secretion of excess fibrin which may lead to |
| begins also referred to as menarche. | | | | abnormal cell formation in the breast and uterine |
| The imbalance is initially characterized by a | | | | tissue while increasing symptoms of PMS. |
| number of factors: | | | | FibroVera also provides fibrinolytic enzymes a |
| -A sudden decrease in DHEA due to stress, aging, | | | | fibrin eating enzymes and cofactors that are |
| poor diet, side effects of prescription drugs etc. | | | | specifically selected to address excess fibrin |
| -Decrease in progesterone effect due to absolute | | | | buildup; the primary components of endometriosis |
| decrease in synthesis secondary to inadequate | | | | or fibroids. A mildly tipping of hormonal equilibration |
| cholesterol down-conversion and increasing | | | | in favor of balance can significantly reduce the |
| insensitivity of progesterone receptors. | | | | speed and intensity at which fibroids can grow. |
| -The activation of a cross-conversion pathway | | | | This allows the fibrinolytic enzymes in FibroVera |
| which then forces progesterone to act as a | | | | to soften, breakup and eventually dissolve |
| source for the synthesis of estrogens thereby | | | | abnormal tissue development without significant |
| decreasing both its bioavailability as a hormone, | | | | opposition. |